KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to $609.5 million.

  • Exact Sciences' Operating Expenses rose 1413.63% to $609.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year increase of 9778.46%. This contributed to the annual value of $3.0 billion for FY2024, which is 4480.25% up from last year.
  • According to the latest figures from Q3 2025, Exact Sciences' Operating Expenses is $609.5 million, which was up 1413.63% from $564.6 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Operating Expenses registered a high of $1.4 billion during Q4 2024, and its lowest value of -$16.4 million during Q4 2023.
  • Over the past 5 years, Exact Sciences' median Operating Expenses value was $609.5 million (recorded in 2025), while the average stood at $594.1 million.
  • In the last 5 years, Exact Sciences' Operating Expenses crashed by 25631.42% in 2023 and then soared by 844354.54% in 2024.
  • Exact Sciences' Operating Expenses (Quarter) stood at $555.0 million in 2021, then tumbled by 98.11% to $10.5 million in 2022, then tumbled by 256.31% to -$16.4 million in 2023, then surged by 8443.55% to $1.4 billion in 2024, then tumbled by 55.56% to $609.5 million in 2025.
  • Its Operating Expenses stands at $609.5 million for Q3 2025, versus $564.6 million for Q2 2025 and $596.6 million for Q1 2025.